(CHFS) – StreetInsider.com Reports
-
CHF Solutions Inc. (CHFS) Prices $18.1 Million Underwritten Public Offering of Common at $5.50/sh
-
CHF Solutions Inc. (CHFS) to Offer Common Stock
-
CHF Solutions Inc. (CHFS) Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems
-
CHF Solutions Inc. (CHFS) Tops Q4 EPS by 13c, Revenues Beat
-
CHF Solutions Inc. (CHFS) Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
-
CHF Solutions Inc. (CHFS) Misses Q3 EPS by 82c, Revenues Beat
-
CHF Solutions Inc. (CHFS) Submits Patent Application to Improve Venous Blood Flow and Ultrafiltration Efficiency
-
CHF Solutions Inc. (CHFS) Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
-
CHF Solutions Inc. (CHFS) Prices of $12.5 Million Underwritten Public Offering of Common Stock, Warrants
-
CHF Solutions Inc. (CHFS) Tops Q2 EPS by $1.16
-
CHF Solutions Inc. (CHFS) Announces Nestor Jaramillo, Jr. to President and COO
-
Maxim Group Starts CHF Solutions (CHFS) at Buy
-
CHF Solutions Inc. (CHFS) Announces Publication Highlights Use of Ultrafiltration for Fluid Management in COVID-19 Patients
-
CHF Solutions (CHFS) PT Lowered to $1.80 at Ladenburg Thalmann
-
CHF Solutions Inc. (CHFS) Prices Direct Offering of 3.6M Shares at $0.4725
-
CHF Solutions Inc. (CHFS) Ships Aquadex Product to COVID-19 Specialty Center in Minnesota
-
CHF Solutions Inc. (CHFS) Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management When Access to Dialysis Machines is Limited or Not Available
-
CHF Solutions Inc. (CHFS) Submits Patent Application for Hemofiltration System for Rapid Clearing of Cytokines in COVID-19 patients
-
CHF Solutions Inc. (CHFS) Announces Pricing of Registered Direct Offering of Common Stock, Warrants
-
CHF Solutions (CHFS) Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
-
CHF Solutions Inc. (CHFS) Prices 4.16M Share Registered Direct Offering at $0.30/Sh
-
CHF Solutions Inc. (CHFS) Granted FDA 510(k) Clearance for Aquadex SmartFlow System in Pediatric Patients Weighing 20kg or More
-
CHF Solutions, Inc. (CHFS) Prices $8.4 Million Underwritten Public Offering of Common Stock, Warrants
-
CHF Solutions, Inc. (CHFS) Misses Q3 EPS by 44c
-
Pre-Open Movers 11/04: (WMGI) (EOLS) (TWOU) Higher; (AVEO) (CHFS) (UAA) Lower (more...)
-
CHF Solutions, Inc. (CHFS) Prices 1.22M Share Registered Direct Offering at $1.12/Sh
-
CHF Solutions, Inc. (CHFS) Pricing 575.83K Share Offering at $1.15/Sh
-
CHF Solutions, Inc. (CHFS) Prices Underwritten Public Unit Offer Valued at Gross Proceeds of Approx. $10.8M
-
CHF Solutions, Inc. (CHFS) Announces Strategic Collaboration with NI Medical on Management of Fluid Overloaded Patients
-
CHF Solutions, Inc. (CHFS) Reports Acquisition of Impedance Technology from Vasamed Inc.
-
Dawson James Starts CHF Solutions (CHFS) at Buy
-
CHF Solutions (CHFS) PT Lowered to $3 at Ladenburg Thalmann
-
CHF Solutions, Inc. (CHFS) Secures $6.5M Contract from U.S. Dept. of Veteran Affairs to Supply Aquadex FlexFlow System for Outpatient Services in Tampa, Fla.
-
CHF Solutions, Inc. (CHFS) Prices 2.21M Common Share Offering at $2.12/Sh
-
CHF Solutions, Inc. (CHFS) Gains on Distribution Agreement in Spain
-
Pre-Open Movers 04/05: (CHFS) (FNSR) (HRTX) Higher; (CNAT) (CHECK) (CONN) Lower (more...)
-
CHF Solutions (CHFS) Signs International Distribution and Services Agreement with Singapore-based TRANSMEDIC
-
CHF Solutions, Inc. (CHFS) Prices $18M Underwritten Public Offering
-
CHF Solutions, Inc. (CHFS) Halted LUDP; Off Highs, Last Up 388%
-
CHF Solutions, Inc. (CHFS) Adds to Gain, Up 470%
-
CHF Solutions, Inc. (CHFS) halted ahead LUDP, last up 201.9% but off highs
-
CHF Solutions, Inc. (CHFS) Halted Again on LUDP, Up 240% but Off High
-
CHF Solutions, Inc. (CHFS) Halted for 5th Time, Shares Up 160%
-
CHF Solutions, Inc. (CHFS) Halted Again on LUDP, Shares Up 48%
-
CHF Solutions, Inc. (CHFS) Halted on LUDP
-
CHF Solutions Inc. (CHFS) Announces 1-for-20 Reverse Share Split
-
Ladenburg Thalmann Starts CHF Solutions (CHFS) at Buy, "Superior Capability & Economics"
-
CHF Solutions (CHFS) Granted FDA IDE Approval for Clinical Study of Aquadex FlexFlow Aquapheresis System for Pediatric Use
Back to CHFS Stock Lookup